Diabetologia
-
Randomized Controlled Trial Multicenter Study Comparative Study
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial.
The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with background metformin. ⋯ ClinicalTrials.gov NCT01106677 FUNDING: This study was supported by Janssen Research & Development, LLC.